Pharmacy Consulting

Pharmacy Healthcare Solutions LLC (PHSL) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSL with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

PHSL is Operating

News & Events

PHSL is Operating

PHSL wants you to know that we are continuing to support our clients during this stressful time, with the majority of our employees telecommuting during this time. Please click for more information.

Coronavirus Preparation Tips

The novel Coronavirus (COVID-19) pandemic is occurring during a time that overlaps with cold and flu season, as well as seasonal allergies. For mild illnesses, including those associated with Coronavirus, supportive care may be the best option. PHSL recommends keeping the following items on hand in case your household is impacted by illness. Many of Read More →

Market Effects from COVID-19

Prescription volume dispensed by retail and mail service pharmacies has increased dramatically in March as a result of COVID-19 concerns.  It is common knowledge that the first week of the month is the busiest in retail pharmacy departments.  Medicare checks are received by seniors and updates are made to the Medicaid eligibility files, leading more Read More →

Latest from the Blog

A Closer Look at COVID-19 Testing at Pharmacies

As of April 8, 2020, pharmacists have been given authorization to order and administer COVID-19 tests under the guidance of the Public Readiness and Emergency Preparedness (PREP) Act. This includes nasal and serology tests. On May 19, 2020, the Office of General Counsel (OGC) released a document answering whether PREP Act preempts state licensing laws Read More →

A New Way to Control Pain

The Food and Drug Administration (FDA) recently gave approval to GlaxoSmithKline (GSK) for their new OTC pain product, Advil Dual Action with Acetaminophen. This pain medication contains 250mg of ibuprofen and 500 mg of acetaminophen. It is the first OTC combination of ibuprofen and acetaminophen for pain control. This combination fights pain in two different Read More →

Non-Alcoholic Steatohepatitis (NASH) Updates

Non-Alcoholic Steatohepatitis (NASH) is characterized by fat accumulation in the liver that causes inflammation and cell damage without regard to alcohol use. If you would like to know more about NASH, please click here to read our previous blog post. The FDA has not approved any medications to treat NASH. This condition is important to Read More →